Go Pro
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
C$10.60
-3.8%		C$10.60
C$3.50
▼
C$15.75
C$168.68MN/A12,671 shs3,402 shs
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
$33.76
+0.1%		$33.40
$27.46
▼
$35.62
$204.25M-0.02142,696 shs26,498 shs
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
C$1.55
+0.6%		C$1.47
C$0.98
▼
C$5.40
C$118.39M0.4338362,164 shs1,850 shs
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
$25.98
$26.08
$25.70
▼
$26.78
$2.75B0.271.20 million shs724,593 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
0.00%0.00%0.00%0.00%0.00%
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
+0.09%-0.27%+1.75%-2.40%+22.41%
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
+0.65%+3.33%+10.71%-5.49%+43.52%
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
0.00%-0.04%-0.46%-0.88%-1.52%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
C$10.60
-3.8%		C$10.60
C$3.50
▼
C$15.75
C$168.68MN/A12,671 shs3,402 shs
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
$33.76
+0.1%		$33.40
$27.46
▼
$35.62
$204.25M-0.02142,696 shs26,498 shs
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
C$1.55
+0.6%		C$1.47
C$0.98
▼
C$5.40
C$118.39M0.4338362,164 shs1,850 shs
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
$25.98
$26.08
$25.70
▼
$26.78
$2.75B0.271.20 million shs724,593 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
0.00%0.00%0.00%0.00%0.00%
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
+0.09%-0.27%+1.75%-2.40%+22.41%
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
+0.65%+3.33%+10.71%-5.49%+43.52%
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
0.00%-0.04%-0.46%-0.88%-1.52%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
0.00
N/AN/AN/A
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
0.00
N/AN/AN/A
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
0.00
N/AN/AN/A
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/AN/AC$3.34 per share3.17C$3.60 per shareN/A
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
N/AN/AN/AN/AN/AN/A
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
N/AN/AC$0.14 per share11.32C$0.19 per shareN/A
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/A-C$0.38N/AN/AN/AN/AN/AN/AN/A
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
-C$50.55M-C$0.04N/AN/AN/AN/A-21.54%-279.98%N/A
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
N/AN/A60.28N/AN/AN/AN/AN/AN/A

Latest BCT, HBP, SCYB, and COM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/12/2026Q3 2026
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
N/A-C$0.01N/A-C$0.01N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/AN/AN/AN/AN/A
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
$0.842.49%N/AN/AN/A
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
N/A1.50%N/AN/AN/A
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
$1.796.89%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
0.05
129.63
128.68
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
N/AN/AN/A
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
2.44
0.45
1.04
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/A
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
N/A
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
0.00%
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
N/A

Insider Ownership

CompanyInsider Ownership
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/A
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
N/A
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
2.15%
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
515.91 millionN/ANot Optionable
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
N/A6.05 millionN/ANot Optionable
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
976.38 millionN/ANot Optionable
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
N/A106.00 millionN/ANot Optionable

Recent News About These Companies

Schwab high yield bond ETF declares monthly distribution of $0.1547
August 3, 2026  |  msn.comhttps://www.msn.com/en-us/money/investment/schwab-high-yield-bond-etf-declares-monthly-distribution-of-0-1547/ar-AA29kjxo
SCYB: A Low-Cost High-Yield Allocation For Both Tactical And Complementary Portfolios
July 29, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4927154-scyb-a-low-cost-high-yield-allocation-for-both-tactical-and-complementary-portfolios
Schwab high yield bond ETF declares $0.1487 dividend
July 2, 2026  |  msn.comhttps://www.msn.com/en-us/money/mutualfunds/schwab-high-yield-bond-etf-declares-01487-dividend/ar-AA270jJ9
SCYB My Choice Among High Yield ETFs
May 14, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4904826-scyb-my-choice-among-high-yield-etfs
Schwab high yield bond ETF declares monthly distribution of $0.1449
May 1, 2026  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/schwab-high-yield-bond-etf-declares-monthly-distribution-of-01449/ar-AA22awNQ
Schwab High Yield Bond ETF declares monthly distribution of $0.1537
April 1, 2026  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/schwab-high-yield-bond-etf-declares-monthly-distribution-of-01537/ar-AA1ZVARm
SCYB: Trouble Not Yet Boiling Over In High Yield
March 1, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4876835-scyb-trouble-not-yet-boiling-over-in-high-yield
Schwab high yield bond ETF declares monthly distribution of $0.1481
December 19, 2025  |  msn.comhttps://www.msn.com/en-us/money/markets/schwab-high-yield-bond-etf-declares-monthly-distribution-of-01481/ar-AA1SGRyi
High-Yield Confidence: Advisors Lean Into Credit in the New Year
December 15, 2025  |  etftrends.comE
SCYB: Cheapest High-Yield Bond ETF, But Not A Buy Right Now (Rating Downgrade)
December 12, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4853084-scyb-cheapest-high-yield-bond-etf-but-not-a-buy-right-now
SCYB: An Ultra-Low-Cost High Yield ETF To Harvest Carry In A Stable-Price Scenario
December 11, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4852518-scyb-an-ultra-low-cost-high-yield-etf-to-harvest-carry-in-a-stable-price-scenario
Schwab High Yield Bond ETF declares monthly distribution of $0.1498
October 1, 2025  |  msn.comhttps://www.msn.com/en-us/money/general/schwab-high-yield-bond-etf-declares-monthly-distribution-of-0-1498/ar-AA1NGeLW
SCYB: An Appealing Low-Cost, High-Yield Bond Portfolio
September 29, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4826609-scyb-an-appealing-low-cost-high-yield-bond-portfolio
CSE Bulletin: Consolidation - Scryb Inc. (SCYB)
August 11, 2025  |  newsfilecorp.comN
SCYB: Passive High Yield ETF From Schwab
July 16, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4801515-scyb-passive-high-yield-etf-from-schwab
Schwab High Yield Bond ETF declares $0.1527 dividend
July 1, 2025  |  msn.comhttps://www.msn.com/en-us/money/mutualfunds/schwab-high-yield-bond-etf-declares-01527-dividend/ar-AA1HLJ78
7 Lowest Expense Ratio ETFs
June 10, 2025  |  money.usnews.comhttps://money.usnews.com/investing/articles/lowest-expense-ratio-etfs
SCYB: Not The Time For High Yield
May 4, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4781628-scyb-not-time-for-high-yield
Schwab High Yield Bond ETF declares $0.1586 dividend
May 2, 2025  |  seekingalpha.comhttps://seekingalpha.com/news/4440260-schwab-high-yield-bond-etf-declares-0_1586-dividend?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=news?source=MarketBeat
Schwab High Yield Bond ETF (SCYB) Dividend History
March 29, 2025  |  nasdaq.comhttps://www.nasdaq.com/market-activity/etf/scyb/dividend-history

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Rocket Lab Electron rocket on coastal launch pad with company logo overlay, symbolizing space tech integration strategy.
Rocket Lab’s Stock Drop Comes With a Bullish Twist
By Ryan Hasson | July 10, 2026
Two Very Large Crude Carriers (VLLCs) sailing side by side on open ocean waters, viewed from above.
Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
By Dan Schmidt | July 19, 2026
Trading screen displaying a candlestick price chart, options calls and puts pricing table, and green call, red put buttons.
The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
By Bridget Bennett | July 20, 2026
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
Ulta Beauty logo illuminated on a backlit display surrounded by makeup products, brushes, and cosmetics on a countertop.
Ulta's Growth Is Real, But So Are the Risks
By Peter Frank | August 5, 2026
BriaCell Therapeutics stock logo

BriaCell Therapeutics CVE:BCT

C$10.60 -0.42 (-3.81%)
As of 12/30/2021

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Direxion Auspice Broad Commodity Strategy ETF stock logo

Direxion Auspice Broad Commodity Strategy ETF NYSEARCA:COM

$33.76 +0.03 (+0.09%)
As of 08/6/2026 04:10 PM Eastern

The Direxion Auspice Broad Commodity Strategy ETF (COM) is an exchange-traded fund that is based on the Auspice Broad Commodity index. The fund tracks a broad-market index consisting of 12 commodity futures contracts, weighted by historical volatility, which can toggle to cash based on momentum. The fund will also hold short-term fixed income securities as collateral. COM was launched on Mar 30, 2017 and is managed by Direxion.

Helix BioPharma stock logo

Helix BioPharma TSE:HBP

C$1.55 +0.01 (+0.65%)
As of 08/6/2026 03:59 PM Eastern

Helix BioPharma is an oncology company that innovates from strength to bring near-term solutions for today's hardest-to-treat cancers. The Company's pipeline is led by Tumor Defense Breaker¿ L-DOS47, a clinical-stage antibody-enzyme conjugate designed to prime CEACAM6-expressing tumors for increased sensitivity to therapy and augment the effectiveness of today's front-running anti-cancer treatments. L-DOS47 has completed Phase Ib studies in non-small cell lung cancer (NSCLC) and shares its CEACAM6-targeting foundation with Helix's next-generation bi-specific antibody-drug conjugates (ADCs), currently in discovery. The Company also advances two pre-IND candidates: (i) LEUMUNA¿, an oral immune checkpoint modulator aimed at achieving durable remission in post-transplant leukemia relapse, and (ii) GEMCEDA¿, a first-in-class oral gemcitabine prodrug with bioavailability on a par with IV, designed to expand treatment options for advanced cancers.

Schwab High Yield Bond ETF stock logo

Schwab High Yield Bond ETF NYSEARCA:SCYB

$25.98 0.00 (0.00%)
As of 08/6/2026 04:10 PM Eastern

The Schwab High Yield Bond ETF (SCYB) is an exchange-traded fund that mostly invests in high yield fixed income. The fund tracks an index of USD-denominated high-yield, US corporate bonds, selected and weighted based on market value. SCYB was launched on Jul 11, 2023 and is managed by Charles Schwab.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas